Are you taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound for weight loss or diabetes management? While these drugs are highly effective, there is a rare but serious side effect you need to know about: potential vision loss.

In this interview, Dr. Jacquie Bowen OD, President of the American Optometric Association (AOA), breaks down the crucial link between GLP-1 drugs and eye health. Learn about the increased risk of conditions like Non-arteritic anterior ischemic optic neuropathy (NAION), diabetic retinopathy, and other vision problems.

Dr. Bowen explains the warning signs to watch for—such as sudden, painless vision changes or dimming in one eye—and why scheduling a comprehensive eye exam with a doctor of optometry is essential before or shortly after starting these medications.

Don't let your weight loss transformation compromise your sight. Listen now to understand the risks and how to protect your vision while managing your health!

For more information, visit the AOA's official resource page: www.aoa.org/glp1
Learn More at GoToHealth Media:
https://gotohealthmedia.com/the-ozempic-blindside-rare-but-serious-eye-risk-jacquie-bowen-od-aoa/

SPECIAL OFFER FOR GOTOHEALTH LISTENERS:

Head to cozyearth.com and use my code GOTOHEALTH for up

to 20% off. And if you get a Post-Purchase Survey, be sure to mention you

heard about Cozy Earth right here!

#Ozempic #GLP1 #WeightLoss #DiabetesManagement #EyeHealth #VisionLoss #OzempicSideEffects #Mounjaro #Wegovy #Zepbound #AOA #Optometry #HealthTips #WeightLossJourney #EyeCare

Learn more about your ad choices. Visit megaphone.fm/adchoices